Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for blood cancer: targeted therapy combo shows promise in phase 2 trial

NCT ID NCT06890884

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 13 times

Summary

This study tests whether a new drug, zilovertamab vedotin, combined with standard chemotherapy (R-CHP) works better than another approved drug combo for people with a specific type of fast-growing blood cancer called GCB diffuse large B-cell lymphoma. About 594 adults who have not had treatment before will take part. The main goal is to see if the cancer completely disappears after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 594 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has histologically confirmed diagnosis of germinal center B-cell (GCB) subtype of diffuse large B-cell lymphoma (DLBCL), by prior biopsy, according to the World Health Organization (WHO) classification of neoplasms of the hematopoietic and lymphoid tissues. * Has positron emission tomography (PET) positive disease at screening, defined as 4 to 5 on the Lugano 5-point scale. * Has received no prior treatment for their DLBCL. * Human immunodeficiency virus (HIV) infected participants must have well controlled HIV on antiretroviral therapy (ART). * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy and have undetectable HBV viral load prior to randomization. * Participants with history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable at screening. Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has a history of transformation of indolent disease to DLBCL. * Has received a diagnosis of primary mediastinal B-cell lymphoma (PMBCL) or Grey zone lymphoma. * Has Ann Arbor Stage I DLBCL. * Has clinically significant (i.e., active) cardiovascular disease: cerebral vascular accident/stroke (\<6 months prior to enrollment), myocardial infarction (\<6 months prior to enrollment), unstable angina, congestive heart failure (New York Heart Association Classification Class ≥II), or serious cardiac arrhythmia requiring medication. * Has clinically significant pericardial or pleural effusion. * Has ongoing Grade \>1 peripheral neuropathy. * Has a demyelinating form of Charcot-Marie-Tooth disease. * HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease. * Has ongoing corticosteroid therapy. * Known additional malignancy that is progressing or has required active treatment within the past 2 years. * Known active central nervous system (CNS) lymphoma. * Has active autoimmune disease that has required systemic treatment in the past 2 years. * Has active infection requiring systemic therapy. * Has active HBV (defined as HBsAg positive and detectable HBV deoxyribonucleic acid (DNA)) and HCV (defined as anti-HCV antibody positive and detectable HCV ribonucleic acid (RNA)) infection. * Has history of stem cell/solid organ transplant.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Germinal center B-cell subtype diffuse large B-cell lymphoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma diffuse large B-cell lymphoma germinal center B-cell type

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lymphoma, large B-cell, diffuse

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    142 sites in 9 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AIDPORT Sp. z o.o. ( Site 0808)

    RECRUITING

    Skórzewo, Greater Poland Voivodeship, 60-185, Poland

  • AZ Delta ( Site 0303)

    RECRUITING

    Roeselare, West-Vlaanderen, 8800, Belgium

  • AZ Sint Jan Brugge-Oostende ( Site 0308)

    RECRUITING

    Bruges, West-Vlaanderen, 8000, Belgium

  • AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0306)

    RECRUITING

    Mechelen, Antwerpen, 2800, Belgium

  • Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131)

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Aichi Cancer Center ( Site 1007)

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Alliance Cancer Specialists (ACS) ( Site 8010)

    RECRUITING

    Sellersville, Pennsylvania, 18960, United States

  • Arcispedale Santa Maria Nuova ( Site 0706)

    RECRUITING

    Reggio Emilia, 42123, Italy

  • Atlantic Health Morristown Medical Center ( Site 0163)

    RECRUITING

    Morristown, New Jersey, 07960, United States

  • Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO ( Site 0702)

    RECRUITING

    Palermo, Sicily, 90146, Italy

  • Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo ( Site 0703)

    RECRUITING

    Alessandria, 15121, Italy

  • Baptist Health Hardin ( Site 0154)

    RECRUITING

    Elizabethtown, Kentucky, 42701, United States

  • Baptist Health Lexington ( Site 0127)

    RECRUITING

    Lexington, Kentucky, 40503, United States

  • Baptist MD Anderson Cancer Center ( Site 0176)

    RECRUITING

    Jacksonville, Florida, 32207, United States

  • Bass Medical Group ( Site 0123)

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Beacon Cancer Care ( Site 0142)

    RECRUITING

    Post Falls, Idaho, 83854, United States

  • Beth Israel Deaconess Medical Center ( Site 0161)

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Boca Raton Regional Hospital-Lynn Cancer Institute ( Site 0130)

    RECRUITING

    Boca Raton, Florida, 33486, United States

  • Bozeman Health Deaconess Hospital ( Site 0183)

    RECRUITING

    Bozeman, Montana, 59715, United States

  • Bristol Haematology and Oncology Centre ( Site 0908)

    RECRUITING

    Bristol, Bristol, City of, BS2 8ED, United Kingdom

  • Cancer Care Associates Of York ( Site 0174)

    RECRUITING

    York, Pennsylvania, 17403, United States

  • Centrum für Hämatologie und Onkologie Bethanien ( Site 0417)

    RECRUITING

    Frankfurt am Main, Hesse, 60389, Germany

  • Christie Hospital NHS Trust ( Site 0901)

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • Churchill Hospital ( Site 0903)

    RECRUITING

    Oxford, Oxfordshire, OX3 7LJ, United Kingdom

  • City of Hope - Phoenix ( Site 0202)

    RECRUITING

    Goodyear, Arizona, 85338, United States

  • City of Hope Comprehensive Cancer Center ( Site 0191)

    RECRUITING

    Duarte, California, 91010, United States

  • Clatterbridge Cancer Centre - Liverpool ( Site 0911)

    RECRUITING

    Liverpool, L7 8YA, United Kingdom

  • Cleveland Clinic - Hillcrest Hospital-Hillcrest Hospital Cancer Center ( Site 0199)

    RECRUITING

    Mayfield Heights, Ohio, 44124, United States

  • Cleveland Clinic Main ( Site 0101)

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • Cliniques Universitaires Saint-Luc ( Site 0302)

    RECRUITING

    Brussels, Bruxelles-Capitale, Region de, 1200, Belgium

  • Colorado West Healthcare System-Grand Valley Oncology ( Site 0165)

    RECRUITING

    Grand Junction, Colorado, 81505, United States

  • Dana Farber Cancer Institute ( Site 0111)

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Dietrich Bonhoeffer Klinikum-Neubrandenburg ( Site 0439)

    RECRUITING

    Neubrandenburg, Mecklenburg-Vorpommern, 17036, Germany

  • Edith Wolfson Medical Center ( Site 0602)

    RECRUITING

    Holon, 5810001, Israel

  • Erie County Medical Center ( Site 0175)

    COMPLETED

    Buffalo, New York, 14215, United States

  • Fairview Hospital-Moll Cancer Center ( Site 0198)

    RECRUITING

    Cleveland, Ohio, 44111, United States

  • Fujita Health University Hospital ( Site 1003)

    RECRUITING

    Toyoake, Aichi-ken, 470-1192, Japan

  • Genesis Cancer and Blood Institute ( Site 0193)

    RECRUITING

    Hot Springs, Arkansas, 71913, United States

  • Georgetown University Medical Center ( Site 0117)

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

  • Guy s & St Thomas NHS Foundation Trust ( Site 0904)

    RECRUITING

    London, London, City of, SE1 9RT, United Kingdom

  • HELIOS Klinikum Wuppertal ( Site 0435)

    RECRUITING

    Wuppertal, North Rhine-Westphalia, 42283, Germany

  • Haddasah Medical Center ( Site 0601)

    RECRUITING

    Jerusalem, 9112001, Israel

  • Hammersmith Hospital ( Site 0915)

    RECRUITING

    London, London, City of, W12 0 HS, United Kingdom

  • Hokkaido University Hospital ( Site 1004)

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Hopital de Jolimont ( Site 0304)

    RECRUITING

    Haine-Saint-Paul, Hainaut, 7100, Belgium

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 0707)

    RECRUITING

    Meldola, Forli-Cesena, 47014, Italy

  • Illinois Cancer Care ( Site 7005)

    RECRUITING

    Peoria, Illinois, 61615, United States

  • Infirmary Cancer Care ( Site 0157)

    RECRUITING

    Mobile, Alabama, 36607, United States

  • Intermountain Healthcare - St. George ( Site 0203)

    RECRUITING

    St. George, Utah, 84790, United States

  • Intermountain Medical Center ( Site 0182)

    RECRUITING

    Murray, Utah, 84107, United States

  • Ironwood Cancer & Research Centers ( Site 0204)

    RECRUITING

    Chandler, Arizona, 85224, United States

  • Istituto Clinico Humanitas ( Site 0704)

    RECRUITING

    Rozzano, Milano, 20089, Italy

  • Istituto Europeo di Oncologia ( Site 0701)

    RECRUITING

    Milan, 20141, Italy

  • Johanniter Krankenhaus Bonn ( Site 0440)

    RECRUITING

    Bonn, North Rhine-Westphalia, 53113, Germany

  • KRH Klinikum Siloah ( Site 0441)

    RECRUITING

    Hanover, Lower Saxony, 30459, Germany

  • Kansai Medical University Hospital ( Site 1006)

    RECRUITING

    Hirakata, Osaka, 573-1191, Japan

  • Klinikum Chemnitz gGmbH ( Site 0405)

    RECRUITING

    Chemnitz, Saxony, 09113, Germany

  • Klinikum Kassel GmbH ( Site 0434)

    RECRUITING

    Kassel, Hesse, 34125, Germany

  • Klinikum Stuttgart. Klinik fur Hamatologie. Onkologie. Palliativmedizin und Stammzelltransplantation ( Site 0419)

    RECRUITING

    Stuttgart, Baden-Wurttemberg, 70174, Germany

  • LMU Klinikum ( Site 0428)

    RECRUITING

    Munich, Bavaria, 81377, Germany

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108)

    RECRUITING

    New York, New York, 10016, United States

  • Lincoln County Hospital ( Site 0906)

    RECRUITING

    Lincoln, Lincolnshire, LN2 5QY, United Kingdom

  • Louisiana State University Health Sciences Shreveport ( Site 0195)

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Mater Misercordiae University Hospital ( Site 0501)

    RECRUITING

    Dublin, D07 R2WY, Ireland

  • Medical College of Wisconsin ( Site 0103)

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Medical Oncology Hematology Consultants (MOHC) ( Site 8007)

    RECRUITING

    Newark, Delaware, 19713, United States

  • Medical University of South Carolina ( Site 0153)

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Mid Florida Hematology and Oncology Center ( Site 0152)

    RECRUITING

    Orange City, Florida, 32763, United States

  • Minnesota Oncology Hematology (MNO) ( Site 8004)

    RECRUITING

    Burnsville, Minnesota, 55337, United States

  • Mission Blood & Cancer Care ( Site 0114)

    RECRUITING

    Waukee, Iowa, 50263, United States

  • Mount Sinai Braman Comprehensive Cancer Center ( Site 0140)

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • NHO Revive Research Institute, LLC ( Site 0121)

    RECRUITING

    Lincoln, Nebraska, 68506, United States

  • Nagasaki University Hospital ( Site 1008)

    RECRUITING

    Nagasaki, 852-8501, Japan

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0803)

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • National Cancer Center Hospital ( Site 1009)

    RECRUITING

    Chūō, Tokyo, 104-0045, Japan

  • National Hospital Organization Sendai Medical Center ( Site 1005)

    RECRUITING

    Sendai, Miyagi, 983-8520, Japan

  • Nippon Medical School Hospital ( Site 1001)

    RECRUITING

    Bunkyo, Tokyo, 113-8603, Japan

  • Northwest Cancer Specialists (Compass Oncology) ( Site 8000)

    RECRUITING

    Vancouver, Washington, 98684, United States

  • Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0185)

    RECRUITING

    Louisville, Kentucky, 40207, United States

  • Novant Health Forsyth Medical Center ( Site 0206)

    RECRUITING

    Winston-Salem, North Carolina, 27103, United States

  • Novant Health Presbyterian Medical Center ( Site 0177)

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Ochsner Clinic Foundation ( Site 0189)

    RECRUITING

    New Orleans, Louisiana, 70121, United States

  • Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic ( Site 0209)

    RECRUITING

    Monroe, Louisiana, 71202, United States

  • Optum Medical Care, PC ( Site 0122)

    RECRUITING

    Westbury, New York, 11590, United States

  • Otto-Von-Guericke-Universitaet Magdeburg ( Site 0411)

    RECRUITING

    Magdeburg, Saxony-Anhalt, 39120, Germany

  • Our Lady of the Lake Physician Group-Medical Oncology ( Site 0180)

    RECRUITING

    Baton Rouge, Louisiana, 70808, United States

  • Palo Verde Cancer Specialists ( Site 0105)

    RECRUITING

    Glendale, Arizona, 85304, United States

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0208)

    RECRUITING

    Mineola, New York, 11501, United States

  • Pratia MCM Krakow ( Site 0804)

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 30-727, Poland

  • Pratia Onkologia Katowice ( Site 0801)

    RECRUITING

    Katowice, Silesian Voivodeship, 40-519, Poland

  • Providence Oncology and Hematology Clinic Westside ( Site 0179)

    RECRUITING

    Portland, Oregon, 97225, United States

  • Providence Portland Medical Center ( Site 0120)

    RECRUITING

    Portland, Oregon, 97213, United States

  • Queen Elizabeth Hospital Birmingham ( Site 0912)

    RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • Rabin Medical Center ( Site 0607)

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus ( Site 0604)

    RECRUITING

    Haifa, 3109601, Israel

  • Rocky Mountain Cancer Centers (RMCC) ( Site 8001)

    RECRUITING

    Aurora, Colorado, 80012, United States

  • Roswell Park Cancer Institute ( Site 0192)

    RECRUITING

    Buffalo, New York, 14263, United States

  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135)

    RECRUITING

    Burbank, California, 91505, United States

  • Royal Devon & Exeter Hospital ( Site 0910)

    RECRUITING

    Exeter, Devon, EX2 5DW, United Kingdom

  • SCRI Oncology Partners ( Site 7002)

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • SSM Health Dean Medical Group ( Site 0106)

    RECRUITING

    Madison, Wisconsin, 53715, United States

  • SUNY Upstate Cancer Center ( Site 0178)

    RECRUITING

    Syracuse, New York, 13210, United States

  • Saint Elizabeth Medical Center Edgewood ( Site 0141)

    RECRUITING

    Edgewood, Kentucky, 41017, United States

  • Sheba Medical Center ( Site 0603)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Shimane University Hospital ( Site 1002)

    RECRUITING

    Izumo, Shimane, 693-8501, Japan

  • Soroka Medical Center ( Site 0606)

    RECRUITING

    Beersheba, 8410101, Israel

  • Sourasky Medical Center ( Site 0608)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Specjalistyczny Szpital im. Dr Alfreda Sokolowskiego w Walbrzychu ( Site 0807)

    RECRUITING

    Wałbrzych, Lower Silesian Voivodeship, 58-309, Poland

  • St Vincent's University Hospital ( Site 0502)

    RECRUITING

    Dublin, Dublin, D04 T6F4, Ireland

  • St. James's Hospital ( Site 0505)

    RECRUITING

    Dublin, D08 E9P6, Ireland

  • Stoke Mandeville Hospital ( Site 0917)

    RECRUITING

    Aylesbury, Buckinghamshire, HP21 8AL, United Kingdom

  • Szpital Specjalistyczny im. Jedrzeja Sniadeckiego w Nowym Saczu ( Site 0806)

    RECRUITING

    Nowy Sącz, Lesser Poland Voivodeship, 33-300, Poland

  • Temple University Hospital ( Site 0133)

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

  • Tennessee Cancer Specialists ( Site 7004)

    RECRUITING

    Knoxville, Tennessee, 37909, United States

  • Texas Oncology - Central/South Texas ( Site 8006)

    RECRUITING

    Austin, Texas, 78705, United States

  • Texas Oncology - Northeast Texas ( Site 8002)

    RECRUITING

    Palestine, Texas, 75801, United States

  • Texas Oncology - San Antonio ( Site 8009)

    RECRUITING

    San Antonio, Texas, 78240, United States

  • Texas Oncology - West Texas ( Site 8008)

    RECRUITING

    Amarillo, Texas, 79124, United States

  • The James Cook University Hospital ( Site 0909)

    RECRUITING

    Middlesbrough, England, TS4 3BW, United Kingdom

  • The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0145)

    COMPLETED

    Tyler, Texas, 75701, United States

  • UT Southwestern Medical Center ( Site 0190)

    RECRUITING

    Dallas, Texas, 75390, United States

  • UZ Leuven ( Site 0301)

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • Uniklinik Erlangen ( Site 0412)

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

  • Universita degli Studi di Napoli Federico II ( Site 0705)

    RECRUITING

    Naples, 80131, Italy

  • UniversitaetsklInikum Tuebingen ( Site 0410)

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Universitaetsklinikum Schleswig-Holstein - Campus Luebeck ( Site 0425)

    RECRUITING

    Lübeck, Schleswig-Holstein, 23562, Germany

  • Universitaetsklinikum Ulm. ( Site 0404)

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

  • Universitaetsklinikum Wuerzburg ( Site 0401)

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

  • University Hospital Limerick ( Site 0503)

    RECRUITING

    Limerick, V94 F858, Ireland

  • University Hospitals Plymouth NHS Trust ( Site 0905)

    RECRUITING

    Plymouth, Devon, PL68DH, United Kingdom

  • University Hospitals of Cleveland ( Site 0155)

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University Of Nebraska Medical Center ( Site 0110)

    RECRUITING

    Omaha, Nebraska, 68198, United States

  • University of Chicago Medical Center ( Site 0126)

    RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Cincinnati Medical Center ( Site 0156)

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Iowa-Holden Comprehensive Cancer Center ( Site 0139)

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of North Carolina Medical Center ( Site 0136)

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • Universitätsklinikum Aachen ( Site 0418)

    RECRUITING

    Aachen, North Rhine-Westphalia, 52074, Germany

  • Universitätsklinikum Jena ( Site 0438)

    RECRUITING

    Jena, Thuringia, 07747, Germany

  • Uniwersyteckie Centrum Kliniczne ( Site 0802)

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • VCU Health Adult Outpatient Pavillion ( Site 0138)

    RECRUITING

    Richmond, Virginia, 23219, United States

  • VITAZ ( Site 0307)

    RECRUITING

    Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium

  • Valley Health Systems - Ridgewood Campus ( Site 0125)

    RECRUITING

    Paramus, New Jersey, 07652, United States

  • Virginia Cancer Specialists, PC ( Site 8003)

    RECRUITING

    Manassas, Virginia, 20110, United States

  • ZIV Medical Center ( Site 0605)

    RECRUITING

    Safed, 13100, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.